Skip to content

CYPH CYPH Other Commercial Liabilities

Other Commercial Liabilities at other companies

Amgen logo
AmgenAMGN
CNT
Canton Strategic Holdings, Inc. Common StockCNTN
CTO
Citius Oncology, Inc.CTOR
Septerna, Inc. logo
Septerna, Inc.SEPN

Other financials

Income statement

See full
Revenue$375.0K
Operating income-$4.8M+69.7%
Net income-$77.2M-400%
EPS (diluted)-$0.46-24.3%

Balance sheet

See full
Cash & equivalents$6.7M-79.6%
Total debt$38.0K-75.3%
Total equity$84.4M+305%
Total assets$87.4M+151%

Cash flow

See full
Operating cash flow-$3.4M+76.3%

Valuation

See full
Market cap$65.19M-54.5%
Enterprise value$58.54M
P/S43.5×

Profitability

See full
Operating margin-2,761.7%
Net margin-2,705.8%

Returns & leverage

See full
Return on equity-108.2%-34.4pp
Debt / equity0.0×
Current ratio27.3×+24.9×

Where this comes from

Reported directly by CYPH in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: CYPH’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CYPH's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CYPH's other commercial liabilities?
CYPH (CYPH) reported other commercial liabilities of $1.97M in Q1 2026.
How has CYPH's other commercial liabilities changed year-over-year?
CYPH's other commercial liabilities decreased by 71.9% year-over-year, from $6.99M to $1.97M.
What is the long-term trend for CYPH's other commercial liabilities?
Over 4 years (2021 to 2025), CYPH's other commercial liabilities has grown at a -21.2% compound annual growth rate (CAGR), from $5.37M to $2.07M.